To further verify the inhibitory effect of XPO1 on bladder cancer, we examined the inhibitory effect of Selinexor, an inhibitor of XPO1, on murine bladder cancer cell lines MB49 and human bladder cancer cell lines T24 and HT1376. This evidence concerns the gene XPO1 and urinary bladder carcinoma.